STING1 and neoplasm: Activation of the cyclic guanosine monophosphate–adenosine monophosphate synthase/STING pathway in the tumor microenvironment leads to strong induction of type I IFNs and proinflammatory cytokines (e.g., IL6, TNFα; ref. 4).